Basics Beam Therapeutics Inc. IPO Date: February 6, 2020 Sector: Healthcare Industry: Biotech Market Cap: $2.11B Activated in VL: True Average Daily Range Avg Daily Range: $1.55 | 3.46% Avg Daily Range (30 D): $0.50 | 2.73% Avg Daily Range (90 D): $0.47 | 2.54% Institutional Daily Volume Avg Daily Volume: .93M Avg Daily Volume (30 D): 2.37M Avg Daily Volume (90 D): 1.99M Trade Size Avg Trade Size (Sh.): 58 Avg Trade Size (Sh.) (30 D): 65 Avg Trade Size (Sh.) (90 D): 68 Institutional Trades Total Inst.Trades: 3,059 Avg Inst. Trade: $3.13M Avg Inst. Trade (30 D): $2.69M Avg Inst. Trade (90 D): $2.65M Avg Inst. Trade Volume: .09M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.84M Avg Closing Trade (30 D): $4.2M Avg Closing Trade (90 D): $4.14M Avg Closing Volume: 135.57K     News Jun 28, 2025 @ 1:10 PM 10 Under-the-Radar Healthcare Stocks With Incredib... Source: Dan Victor Jun 17, 2025 @ 2:07 PM Editas Medicine Is Great. Here's Why You Shouldn't... Source: Dan Victor May 29, 2025 @ 8:01 PM Beam Therapeutics Announces U.S. FDA Orphan Drug D... Source: N/A May 6, 2025 @ 9:05 PM Why Beam Therapeutics Stock Tanked on Tuesday Source: Eric Volkman Mar 10, 2025 @ 10:01 AM Beam Therapeutics Announces Pricing of Underwritte... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-4.5 $-1 $-1.24 Diluted EPS $-4.5 $-1 $-1.24 Revenue $ 60.27M $ 8.47M $ 7.47M Gross Profit $ $ $ Net Income / Loss $ -398.58M $ -102.29M $ -109.27M Operating Income / Loss $ -445.98M $ -120.15M $ -119.29M Cost of Revenue $ $ $ Net Cash Flow $ -10.15M $ -245.75M $ 244.41M PE Ratio